Fasting’s potential in fighting cognitive decline needs more human trials

FHS
April 2, 2024
4:14 am

Despite promising animal studies on fasting and caloric restrictions for neurodegenerative diseases, human clinical trials are scarce, underscoring the need for more research to validate these interventions for cognitive decline.

Prime Medicine lays off workers as it trims pipeline

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Good morning to everyone except

October 9, 2024

Unraveling the rhythmic gene expression in legume-rhizobia symbiosis

Legumes thrive in low-nitrogen environments by partnering with rhizobia, soil bacteria that convert atmospheric nitrogen into ammonium, a usable form for the plants.

July 19, 2024

Potrero Medical Files for Chapter 11 Bankruptcy, Aims to Reorganize and Refocus on Patient Care

What You Should Know: – Potrero Medical, Inc., a company developing innovative solutions for monitoring and improving kidney health, announced today it has filed for

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.